Nan Fung Group Holdings Ltd - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 54 filers reported holding ENTRADA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Nan Fung Group Holdings Ltd ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$775,496
+4.4%
49,0820.0%0.63%
+32.2%
Q2 2023$743,101
-30.4%
49,082
-33.3%
0.48%
-34.6%
Q1 2023$1,066,939
+7.2%
73,5820.0%0.73%
+6.0%
Q4 2022$994,829
-55.4%
73,582
-48.0%
0.68%
-51.9%
Q3 2022$2,232,000
+5.6%
141,593
-18.4%
1.42%
-1.9%
Q2 2022$2,114,000
+29.7%
173,5820.0%1.45%
+87.8%
Q1 2022$1,630,000173,5820.77%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$8,042,56353.88%
MPM ASSET MANAGEMENT LLC 4,425,784$69,927,38737.45%
5AM Venture Management, LLC 4,408,379$69,652,38820.04%
StepStone Group LP 761,277$12,028,1772.68%
TCG Crossover Management, LLC 584,955$9,242,2891.36%
Redmile Group, LLC 1,284,000$20,287,2000.96%
Nan Fung Group Holdings Ltd 49,082$775,4960.63%
Baker Brothers Advisors 4,865,819$76,879,9400.44%
Corton Capital Inc. 10,485$165,6630.08%
CORNERCAP INVESTMENT COUNSEL INC 13,977$220,8370.04%
View complete list of ENTRADA THERAPEUTICS INC shareholders